Bay Street News, January, 2019

–  Trial continues as planned with enrollment target of 350 patients  – –  Top-line data readout expected in the first […]

NEW YORK, Jan. 02, 2019 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) announced today […]

LEIDEN, Netherlands & CAMBRIDGE, Mass., Jan. 02, 2019 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing […]

NEWTON, Mass., Jan. 02, 2019 (GLOBE NEWSWIRE) — Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced that Michael […]

Full-Year 2018 Revenue Expected to be Between $113 Million and $115 Million Anticipated Revenues Exceed Current Revenue Guidance of $102 […]

New Terms Provide for Continued Access to $40 Million in Debt Funding $10 Million of the $40 Million Funded at Closing […]

CRESTWOOD, Ky., and WALTHAM Mass., Jan. 02, 2019 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals Inc. (Nasdaq:APLS), a clinical-stage biopharmaceutical company focused […]

TORONTO, Jan. 02, 2019 (GLOBE NEWSWIRE) — Cardinal Resources Limited (ASX: CDV) (“Cardinal” or “the Company”) is pleased to announce […]

TORONTO, Jan. 02, 2019 (GLOBE NEWSWIRE) — Crystal Peak Minerals Inc. (Crystal Peak or the Company) (TSXV: CPM, OTCQX: CPMMF) […]

SAN DIEGO, Jan. 02, 2019 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company developing first-in-class antibody product […]